BaseSpace
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. rs7903146, DNMT1, T cell differentiation, Breast Cancer, Leukocyte, Neocentromeres)
Bookmark Forward

QuickView for zymogen activation (biogroup)


Body Atlas

Most Correlated Tissues

  1. Liver
  2. Fetal liver
  3. Medulla
  4. Spinal cord
  5. Testes
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Alpha-1-antitrypsin deficiency
  2. Disorder of digestive system
  3. Metabolic finding
  4. Severe acute respiratory syndrome
  5. Viral disease
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. CGP 60474
  2. AT 7519
  3. flavopiridol
  4. OTS-167
  5. BMS 387032
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. Ar
  2. DROSHA
  3. DIDO1
  4. TXNRD1
  5. INSM1
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

  1. Lymphotoxin-beta receptor blockade in lacrimal glands in a mouse model of Sjögren's syndrome
  2. Thyroid gene expression in response to exposure to Astatine-211 (211At)
  3. Salivary gland development in murine model of Sjögren's syndrome-like disease
  4. Muscle gene expression profiles in 3 mouse models of spinal bulbar muscular atrophy (SBMA)
  5. L1000 CMAP - Prostate cancer LNCAP cells treated with small molecule perturbagens
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Mechanisms of caspase activation.
  2. Linear mixed irreversible inhibition of the autocatalytic activation of zymogens. Kinetic analysis c…
  3. MECHANISM OF ZYMOGEN ACTIVATION.
  4. THE N-TERMINAL SEQUENCE OF BOVINE CARBOXYPEPTIDASE A AND ITS RELATION OF ZYMOGEN ACTIVATION.
  5. Recommended nomenclature for blood clotting-zymogens and zymogen activation products of the internat…
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Prevention of Infection and Incidence of COVID-19 in Medical Personnel Assisting Patients With New C…
  2. Circulating Markers for Ischemic Heart Disease
  3. Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure
  4. High-dose Furmonertinib Combined With Bevacizumab and Intrathecal Pemetrexed Chemotherapy in Patient…
  5. Factor XIII and Other Biomarkers in ST Segment Elevation Myocardial Infarction
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.